Cargando…
Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665251/ http://dx.doi.org/10.1182/blood-2022-162365 |
| _version_ | 1784831250129747968 |
|---|---|
| author | Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare |
| author_facet | Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare |
| author_sort | Bryer, Emily |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652512022-11-16 Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665251/ http://dx.doi.org/10.1182/blood-2022-162365 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Bryer, Emily Paul, Shira Chen, Jonathan Pleyer, Christopher Wiestner, Adrian Sun, Clare Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL |
| title | Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL |
| title_full | Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL |
| title_fullStr | Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL |
| title_full_unstemmed | Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL |
| title_short | Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL |
| title_sort | booster and btki interruption improve response to sars-cov-2 vaccine in patients with cll |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665251/ http://dx.doi.org/10.1182/blood-2022-162365 |
| work_keys_str_mv | AT bryeremily boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT paulshira boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT chenjonathan boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT pleyerchristopher boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT wiestneradrian boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll AT sunclare boosterandbtkiinterruptionimproveresponsetosarscov2vaccineinpatientswithcll |